Skip to main navigation Skip to search Skip to main content

Development of 99mtc-neomannosyl human serum albumin (99mtc-msa) as a novel receptor binding agent for sentinel lymph node imaging

  • Jae Min Jeong
  • , Mee Kyung Hong
  • , Young Joo Kim
  • , Jaetae Lee
  • , Joo Hyun Kang
  • , Dong Soo Lee
  • , June Key Chung
  • , Myung Chul Lee
  • Seoul National University

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

Various mannose receptor-binding agents, for example 99mTc-diethylenetriaminepentaacetic acid (DTPA)-mannosyl-polymer, have been developed for sentinel lymph node (SLN) imaging. In order to simplify the synthesis and labelling procedure and to improve the biological properties, we developed a novel mannose receptor-binding agent, 99mTc-neomannosyl human serum albumin (99mTc-MSA), for SLN imaging.

Original languageEnglish
Pages (from-to)1211-1217
Number of pages7
JournalNuclear Medicine Communications
Volume25
Issue number12
DOIs
StatePublished - Dec 2004

Keywords

  • Lymphoscintigraphy
  • Neomannosyl human serum albumin (MSA)
  • Sentinel node imaging

Fingerprint

Dive into the research topics of 'Development of 99mtc-neomannosyl human serum albumin (99mtc-msa) as a novel receptor binding agent for sentinel lymph node imaging'. Together they form a unique fingerprint.

Cite this